{"title":"Cerebral Complications Following Facial Autologous Fat Graft Injection: A Systematic Review and Meta-analysis.","authors":"Yimei Han, Chen Liu, Guoping Wu","doi":"10.1007/s00266-024-04268-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>With the increasing use of autologous fat (AF) grafting in plastic surgery, the occurrence of complications has garnered the attention from plastic surgeons. This study aims to estimate the cerebral complications following facial AF graft injection objectively and systematically with newly published literature.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted systematically on PubMed, Embase, Web of Science, Cochrane, and ClinicalTrials.gov for articles published between 2000 and 2023. A systematic review and meta-analysis were performed in accordance with PRISMA guidelines.</p><p><strong>Results: </strong>A total of 11 articles comprising of 37 participants were included, all of which are case reports. For AF facial filling, the incidence rate of cerebral embolism among cases of cerebral and ocular embolism was found to be 60% (95% CI 0.41-0.79). The incidence of cerebral embolism presenting with initial symptoms of unconsciousness was 69% (95% CI 0.48-0.9), with limb movement disorders was 55% (95% CI 0.26-0.84), and with vision loss was 30% (95% CI 0.12-0.49). The incidence of cerebral embolism with ophthalmic artery occlusion was 36% (95% CI 0.20-0.53), compared to was 71% (95% CI 0.48-0.95) without ophthalmic artery occlusion.</p><p><strong>Conclusions: </strong>AF grafting is generally safe and minimally invasive. However, with its widespread use as facial injection filling for cosmetic enhancement, the incidence of cerebral complications, such as cerebral infarction, has also increased. It is imperative to properly manage high-risk factors for cerebral embolism during the perioperative period to prevent its occurrence.</p><p><strong>Level of evidence iii: </strong>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00266-024-04268-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: With the increasing use of autologous fat (AF) grafting in plastic surgery, the occurrence of complications has garnered the attention from plastic surgeons. This study aims to estimate the cerebral complications following facial AF graft injection objectively and systematically with newly published literature.
Methods: A comprehensive literature search was conducted systematically on PubMed, Embase, Web of Science, Cochrane, and ClinicalTrials.gov for articles published between 2000 and 2023. A systematic review and meta-analysis were performed in accordance with PRISMA guidelines.
Results: A total of 11 articles comprising of 37 participants were included, all of which are case reports. For AF facial filling, the incidence rate of cerebral embolism among cases of cerebral and ocular embolism was found to be 60% (95% CI 0.41-0.79). The incidence of cerebral embolism presenting with initial symptoms of unconsciousness was 69% (95% CI 0.48-0.9), with limb movement disorders was 55% (95% CI 0.26-0.84), and with vision loss was 30% (95% CI 0.12-0.49). The incidence of cerebral embolism with ophthalmic artery occlusion was 36% (95% CI 0.20-0.53), compared to was 71% (95% CI 0.48-0.95) without ophthalmic artery occlusion.
Conclusions: AF grafting is generally safe and minimally invasive. However, with its widespread use as facial injection filling for cosmetic enhancement, the incidence of cerebral complications, such as cerebral infarction, has also increased. It is imperative to properly manage high-risk factors for cerebral embolism during the perioperative period to prevent its occurrence.
Level of evidence iii: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
背景:随着自体脂肪(AF)移植在整形外科中的应用越来越广泛,并发症的发生引起了整形外科医生的关注。本研究旨在通过最新发表的文献,客观、系统地估计面部自体脂肪移植注射后的脑部并发症:方法:在PubMed、Embase、Web of Science、Cochrane和ClinicalTrials.gov上对2000年至2023年间发表的文章进行了全面系统的文献检索。根据 PRISMA 指南进行了系统综述和荟萃分析:结果:共纳入 11 篇文章,37 名参与者,全部为病例报告。对于房颤面部充盈,在脑栓塞和眼部栓塞病例中,脑栓塞的发生率为 60%(95% CI 0.41-0.79)。最初出现昏迷症状的脑栓塞发生率为 69%(95% CI 0.48-0.9),出现肢体运动障碍的脑栓塞发生率为 55%(95% CI 0.26-0.84),出现视力下降的脑栓塞发生率为 30%(95% CI 0.12-0.49)。眼动脉闭塞的脑栓塞发生率为36%(95% CI 0.20-0.53),而无眼动脉闭塞的脑栓塞发生率为71%(95% CI 0.48-0.95):AF移植术通常是安全和微创的。结论:房颤移植总体上是安全和微创的,但随着其作为面部注射填充物用于美容的广泛应用,脑并发症(如脑梗塞)的发生率也在增加。当务之急是在围手术期妥善处理脑栓塞的高危因素,防止脑栓塞的发生:本期刊要求作者为每篇文章指定证据级别。有关这些循证医学等级的完整描述,请参阅目录或在线作者须知 www.springer.com/00266 。